News

Cigna and CVS shares fall as Trump targets ‘middlemen’ in sweeping executive order against Big Pharma
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
This Drug Is Nearly 50 Percent More Effective Than Wegovy
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
Pharma stocks recover from initial shock of Trump's drug pricing order
By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...
CVS opts for Wegovy over Zepbound, affecting drug access for some
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...
Pharma stocks erase early losses driven by Trump's plans to cut drug prices
In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.
BioSpace13h
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
EconoTimes1d
Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Head-to-Head Trial
Eli Lilly announced that its obesity drug Zepbound outperformed Novo Nordisks Wegovy in a direct comparison across five key ...
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
Eli Lilly, Purdue create $250 million partnership for pharma research as federal cuts hit labs
Eli Lilly and Purdue University announced a $250 million in what the two institutions say is the largest industry-academic partnership in the country.